Genmab A (GMAB) Cash from Investing Activities (2023 - 2026)

Genmab A's Cash from Investing Activities history runs 4 years deep, the most recent figure standing at -$9.0 million for Q1 2026.

• Quarterly Cash from Investing Activities rose 79.07% year-over-year to -$9.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$140.0 million (up 96.84% YoY) and the FY2025 annual result came in at -$5.6 billion, down 289.98% from the prior year.
• Cash from Investing Activities was -$9.0 million for Q1 2026 at Genmab A, up from -$71.0 million in the prior quarter.
• Across five years, Cash from Investing Activities topped out at -$9.0 million in Q1 2026 and bottomed at -$1.5 billion in Q2 2024.
• A 4-year average of -$546.8 million and a median of -$185.0 million in 2023 frame the typical range for Cash from Investing Activities.
• Annual changes were most pronounced in 2024 — Cash from Investing Activities slumped 682.16% — and 2025, when it jumped 98.85%.
• Genmab A's Cash from Investing Activities stood at -$185.0 million in 2023, then slumped by 682.16% to -$1.4 billion in 2024, then soared by 95.09% to -$71.0 million in 2025, then jumped by 87.32% to -$9.0 million in 2026.
• Business Quant data shows GMAB's Cash from Investing Activities at -$9.0 million in Q1 2026, -$71.0 million in Q3 2025, and -$17.0 million in Q2 2025.